🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
6.38
-0.21 (-3.19%)
Nov 20, 2026, 4:00 PM EST - Market closed

Profound Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
13.136.372.440.3923.15
Other Revenue
10.499.738.246.814.683.72
23.6316.110.687.26.686.87
Revenue Growth
65.26%50.73%48.35%7.75%-2.79%-5.90%
Cost of Revenue
6.184.713.642.893.663.92
Gross Profit
17.4511.397.044.313.022.95
Selling, General & Admin
30.7332.0523.1318.5417.9317.97
Research & Development
20.9920.616.9714.4214.6915.28
Operating Expenses
51.7352.6540.132.9632.6233.24
Operating Income
-34.28-41.25-33.06-28.65-29.6-30.29
Interest Expense
-----0.17-0.07
Interest & Investment Income
1.071.071.440.780.80.21
Currency Exchange Gain (Loss)
0.82-2.133.81-0.583.1-0.29
Other Non Operating Income (Expenses)
----0.02-0.16
EBT Excluding Unusual Items
-32.39-42.32-27.82-28.45-25.86-30.59
Impairment of Goodwill
-----2.52-
Pretax Income
-32.39-42.32-27.82-28.45-28.38-30.59
Income Tax Expense
0.10.25-0-0.130.290.11
Net Income
-32.49-42.57-27.82-28.32-28.67-30.7
Net Income to Common
-32.49-42.57-27.82-28.32-28.67-30.7
Net Income Growth
------
Shares Outstanding (Basic)
353025212120
Shares Outstanding (Diluted)
353025212120
Shares Change
20.36%22.08%16.91%1.69%1.79%18.33%
EPS (Basic)
-0.93-1.41-1.12-1.34-1.38-1.50
EPS (Diluted)
-0.93-1.41-1.12-1.34-1.38-1.50
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-31.67-38.38-23.45-22.61-25.8-22.39
Free Cash Flow Per Share
-0.91-1.27-0.95-1.07-1.24-1.09
Gross Margin
73.86%70.77%65.89%59.90%45.22%42.95%
Operating Margin
-145.08%-256.27%-309.57%-397.99%-443.08%-440.73%
Profit Margin
-137.51%-264.44%-260.45%-393.43%-429.11%-446.66%
Free Cash Flow Margin
-134.04%-238.43%-219.60%-314.06%-386.17%-325.80%
EBITDA
-33.8-40.69-32.13-27.72-28.83-29.61
EBITDA Margin
-143.06%-252.79%----
D&A For EBITDA
0.480.560.940.930.780.68
EBIT
-34.28-41.25-33.06-28.65-29.6-30.29
EBIT Margin
-145.07%-256.27%----
Revenue as Reported
23.6316.110.687.26.686.87
SEC Filings: 10-K · 10-Q